A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2011
06/23/2011	US20110150917 Small Cationic Antimicrobial Peptides
06/23/2011	US20110150916 Compositions and methods for treatment of group a streptococci
06/23/2011	US20110150915 Polyvalent vaccine
06/23/2011	US20110150914 Compositions and methods for dengue virus (dv) treatment and vaccination
06/23/2011	US20110150913 Torque teno virus (ttv) isolates and compositions
06/23/2011	US20110150912 Avian influenza virus live attenuated vaccine and uses thereof
06/23/2011	US20110150911 Methods and reagents for treating, preventing and diagnosing bunyavirus infection
06/23/2011	US20110150907 Methods and materials for gastrointestinal delivery of pathogen/toxin binding agents
06/23/2011	US20110150904 Therapeutic Antibodies for Treatment and Prophylaxis of Transmittable Viral Diseases
06/23/2011	US20110150897 Influenza targets
06/23/2011	US20110150896 Antibody against PCRV
06/23/2011	US20110150892 Human antibodies that bind lymphocyte activation gene-3 (lag-3) and uses thereof
06/23/2011	US20110150889 Haemophilus influenzae type iv pili
06/23/2011	US20110150880 Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
06/23/2011	US20110150870 Fully human anti-human nkg2d monoclonal antibodies
06/23/2011	US20110150865 Antibodies to lymphotoxin-alpha
06/23/2011	US20110150860 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
06/23/2011	US20110150854 Riboswitches, methods for their use, and compositions for use with riboswitches
06/23/2011	US20110150852 Novel Strain of Lactobacillus Paracasei Subspecies Paracasei Having Antimicrobial and Immunomodulatory Properties
06/23/2011	US20110150851 Nutritional composition for infants delivered via caesarean section
06/23/2011	US20110150841 Secretion System and Methods for its Use
06/23/2011	US20110150836 Methods of treating hbv and hcv infection
06/23/2011	US20110150835 Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease
06/23/2011	US20110150833 Benzopyrans and analogs as rho kinase inhibitors
06/23/2011	US20110150830 Covalent conjugates between endoperoxides and transferrin and lactoferrin receptor-binding agents
06/23/2011	US20110150829 Antiviral nucleosides
06/23/2011	US20110150827 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
06/23/2011	US20110150824 Nutritional Composition for Improving the Mammalian Immune System
06/23/2011	US20110150796 Precipitation polymerization in the presence of glycerin monostearate
06/23/2011	US20110150780 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
06/23/2011	US20110150771 Chimeric west nile/dengue viruses
06/23/2011	US20110150770 Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine
06/23/2011	US20110150757 Compounds for inhibiting ksp kinesin activity
06/23/2011	CA2784748A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
06/23/2011	CA2784646A1 Hcv combination therapy
06/23/2011	CA2784624A1 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof
06/23/2011	CA2784087A1 Mannose derivatives as antagonists of bacterial adhesion
06/23/2011	CA2784015A1 Use of a cationic, advantageously amphoteric, surfactant for the preparation of an antifungal solution that can be applied to the nail
06/23/2011	CA2783891A1 Antifungal composition intended to be applied to a perforated nail
06/23/2011	CA2782524A1 3'-deoxy-3'-methylidene-.beta.-l-nucleosides
06/23/2011	CA2782453A1 N-linked hydroxamic acid derivatives useful as antibacterial agents
06/23/2011	CA2780526A1 Heterocyclic antiviral compounds
06/23/2011	CA2780290A1 Mk2 inhibitors
06/23/2011	CA2780006A1 Tricyclic antibiotics
06/22/2011	EP2336370A2 Recombinant Newcastle disease virus RNA expression systems and vaccines
06/22/2011	EP2336357A1 S. pneumoniae antigens
06/22/2011	EP2336187A2 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
06/22/2011	EP2336186A1 Humanized antibodies against ICAM-1, their production and uses
06/22/2011	EP2336179A1 Stabilized single domain antibodies
06/22/2011	EP2336167A1 MHC molecule constructs and their uses for diagnosis and therapy
06/22/2011	EP2336151A1 Replikin peptides and uses thereof
06/22/2011	EP2336150A2 Replikin peptides and uses thereof
06/22/2011	EP2336135A2 1-[2',3'-dideoxy-3'c-(hydroxymethyl)- beta-d-erythro-pentofuranosyl]cytosine derivatives as HIV inhibitors
06/22/2011	EP2336134A1 Fitness assay and methods for reducing resistance of HIV to therapy
06/22/2011	EP2336133A1 Purine analogs having HSP90-inhibiting activity
06/22/2011	EP2336115A1 Dihydropyrimidine compounds and use thereof for the treatment of viral diseases
06/22/2011	EP2336111A1 Heterocyclic inhibitors of p38
06/22/2011	EP2336108A1 Hybrid tripyrrole-octaarginine compounds and their use as medicament in the treatment of cancer and microbial illnesses
06/22/2011	EP2335779A1 Small Molecule Inhibitors of Retroviral Assembly & Maturation
06/22/2011	EP2335724A1 Immunisation against chlamydia trachomatis
06/22/2011	EP2335723A1 Immunisation against chlamydia trachomatis
06/22/2011	EP2335717A1 PAR-1 antagonists for use in the treatment or prevention of influenza virus type a infections
06/22/2011	EP2335705A1 Use of sphingomyelin for the treatment of influenza
06/22/2011	EP2335701A1 Heterocyclic aspartyl protease inhibitors
06/22/2011	EP2335700A1 Hepatitis C virus polymerase inhibitors with a heterobicylic structure
06/22/2011	EP2334706A1 Identification of a conserved inner core oligosaccharide region of moraxella catarrhalis lipopolysaccharide as a vaccine antigen
06/22/2011	EP2334700A2 Dengue virus neutralizing antibodies and uses thereof
06/22/2011	EP2334694A1 Viral polypeptides and methods
06/22/2011	EP2334681A1 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors
06/22/2011	EP2334680A2 Hcv protease inhibitors
06/22/2011	EP2334675A1 Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
06/22/2011	EP2334674A1 Pyridazino- pyridinone compounds for the treatment of protein kinase mediated diseases.
06/22/2011	EP2334662A1 Pyrine or pyrazine derivatives for treating hcv
06/22/2011	EP2334656A1 Triazole compounds, use thereof, and agents containing same
06/22/2011	EP2334379A2 Host cell kinases as targets for antiviral therapies against hcv infection
06/22/2011	EP2334333A1 Polymer conjugates of v681-like peptides
06/22/2011	EP2334327A1 West nile virus vaccine
06/22/2011	EP2334321A2 Analysis of hcv genotypes
06/22/2011	EP2334318A2 Hiv-1 integrase derived stimulatory peptides interfering with integrase - rev protein binding
06/22/2011	EP2334301A1 Macrocyclics pyrimidines as aurora kinase inhibitors
06/22/2011	EP2334298A2 Novel single unit carbapenem aminoglycoside formulations
06/22/2011	EP2174143B1 Use of procalcitonin (pct) in risk stratification and prognosis of patients with a primary, non-infectious disease
06/22/2011	EP1994020B1 Substituted quinolones III
06/22/2011	EP1797111B1 Acylsulfonamide compounds as inhibitors of hepatitis c virus ns3 serine protease
06/22/2011	EP1724342B1 Process for preparing variant of erysipelothrix rhusiopathiae surface protective antigen in e. coli
06/22/2011	EP1546174B1 Methods and compositions for rna interference
06/22/2011	EP1506007B1 Mucosal combination vaccines for bacterial meningitis
06/22/2011	EP1324771B1 Therapeutic and tolerance inducing antibodies
06/22/2011	EP1290161B1 METHODS FOR MEDIATING GENE SUPPRESION BY USING FACTORS THAT ENHANCE RNAi
06/22/2011	EP1207876B1 Use of a modulator which acts on a growth factor precursor in order to inhibit growth factor precursor processing
06/22/2011	EP1109827B1 Bioactive peptides
06/22/2011	DE102009058769A1 Temperaturabhängige Aktivierung von katalytischen Nukleinsäuren zur kontrollierten Wirkstofffreisetzung Temperature-dependent activation of catalytic nucleic acids for controlled drug release
06/22/2011	CN1981040B Recombinant virus vector for gene introduction in lymphocyte
06/22/2011	CN1891714B Ligand for herpes simplex virus entry mediator and methods of use
06/22/2011	CN1850256B Pill for treating hepatitis B
06/22/2011	CN1845734B Benzimidazole derivatives and their use as protein kinases inhibitors
06/22/2011	CN1244896B Non-M, non-O, HIV-1 strains, fragments and applications
06/22/2011	CN102105473A Tricyclic nitrogen containing compounds and their use as antibacterials
06/22/2011	CN102105470A Anti-infective compounds
06/22/2011	CN102105469A Heterocyclic urea derivatives for the treatment of bacterial infections

1 ... 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 ... 1798